...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: J&J Abiraterone going generic
4
Nov 21, 2018 02:31PM

Bloomberg News TV

Share
New Message
Please login to post a reply